2. UroToday Home
  3. Video Lectures

Video Lectures from Keane's Corner

HERO Trial: Oral Relugolix for ADT in Advanced Prostate Cancer - Thomas Keane
August 13, 2021
Details
Personalized Therapy with Erdafitinib: A Biomarker-Targeted Therapy for Urothelial Cancer - Arlene Siefker-Radtke
August 26, 2020
Details
PROfound: Olaparib for Metastatic Castrate Resistant Prostate Cancer - Thomas Keane
July 2, 2020
Details
AUA 2020 Review: Genomic Heterogeneity in Tissue-Based Prognostic Signatures from Prostate Biopsies: The Results From Two Prospective Trials - Thomas Keane
June 25, 2020
Details
AUA 2020 Review: Using Biomarkers in Patients with a Positive Multiparametric MRI: 4Kscore Predicts Presence of Cancer Outside the Index Lesion - Thomas Keane
June 25, 2020
Details
Developments in Imaging Prior to Biopsy — Are Systematic Biopsies Still Required - Tom Keane
January 27, 2020
Details
KEYNOTE-057 in High-Risk, Non-Muscle Invasive Bladder Cancer: Trial Highlights by Tom Keane
December 7, 2018
Details
Effectiveness of Radical Prostatectomy with Adjuvant Radiotherapy versus Radiotherapy Plus ADT for Men with Advanced Prostate Cancer - Tom Keane
November 30, 2018
Details
CARMENA in mRCC and Surgical Management Cases in Bladder Cancer from ASCO 2018 - Tom Keane
June 23, 2018
Details
Prostate Cancer Highlights from AUA 2018 with Tom Keane
June 13, 2018
Details
The Changing Landscape in Advanced Bladder Cancer - Tom Keane
April 19, 2018
Details
New Concepts in ADT- Thomas Keane
April 8, 2018
Details
Discussion of an Online Tool to Explore Evolving Practice Patterns in Renal Cell Carcinoma - Thomas Keane
February 22, 2018
Details
Discussion of the IMmotion 151 Trial: Atezolizumab Plus Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma - Thomas Keane
February 22, 2018
Details
Discussion of the CABOSUN trial - Advanced Renal Cell Carcinoma - Thomas Keane
February 21, 2018
Details
Discussion on FALCON: Impact of 18F-fluciclovine PET/CT on Clinical Management Choices for Men with Biochemically Recurrent Prostate Cancer
February 15, 2018
Details
Discussion on SPARTAN: A Study of Apalutamide in Men with Non-Metastatic Castration-resistant Prostate Cancer - Thomas Keane
February 14, 2018
Details
News Update: Apalutamide as a Treatment for Non-Metastatic Castration-Resistant Prostate Cancer - Thomas Keane
January 3, 2018
Details